JP2018523648A5 - - Google Patents

Download PDF

Info

Publication number
JP2018523648A5
JP2018523648A5 JP2018503784A JP2018503784A JP2018523648A5 JP 2018523648 A5 JP2018523648 A5 JP 2018523648A5 JP 2018503784 A JP2018503784 A JP 2018503784A JP 2018503784 A JP2018503784 A JP 2018503784A JP 2018523648 A5 JP2018523648 A5 JP 2018523648A5
Authority
JP
Japan
Prior art keywords
salt
composition
composition according
acid
citric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018503784A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018523648A (ja
JP6910072B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2016/008924 external-priority patent/WO2017030328A1/ko
Publication of JP2018523648A publication Critical patent/JP2018523648A/ja
Publication of JP2018523648A5 publication Critical patent/JP2018523648A5/ja
Application granted granted Critical
Publication of JP6910072B2 publication Critical patent/JP6910072B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018503784A 2015-08-18 2016-08-12 チモシンベータ４およびクエン酸を活性成分として含む角膜損傷予防／治療用組成物 Active JP6910072B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20150116089 2015-08-18
KR10-2015-0116089 2015-08-18
PCT/KR2016/008924 WO2017030328A1 (ko) 2015-08-18 2016-08-12 티모신 베타4 및 시트르산을 유효성분으로 포함하는 각막 손상 예방 또는 치료용 조성물

Publications (3)

Publication Number Publication Date
JP2018523648A JP2018523648A (ja) 2018-08-23
JP2018523648A5 true JP2018523648A5 (enExample) 2019-09-19
JP6910072B2 JP6910072B2 (ja) 2021-07-28

Family

ID=58050857

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018503784A Active JP6910072B2 (ja) 2015-08-18 2016-08-12 チモシンベータ４およびクエン酸を活性成分として含む角膜損傷予防／治療用組成物

Country Status (6)

Country Link
US (1) US9867868B2 (enExample)
EP (1) EP3338792B1 (enExample)
JP (1) JP6910072B2 (enExample)
KR (1) KR20170021745A (enExample)
ES (1) ES2895923T3 (enExample)
WO (1) WO2017030328A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102696362B1 (ko) 2017-02-17 2024-08-20 삼성전자주식회사 전자 장치 및 전자 장치의 체성분 측정 방법
KR101910908B1 (ko) * 2017-06-14 2018-10-24 (주)휴온스 Gly-Tβ4 (Gly-티모신β4)을 함유하는 안구건조증 치료용 약학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003223601A1 (en) * 2002-04-12 2003-10-27 King's College London ANTI-INFLAMMATORY AND WOUND HEALING EFFECTS OF LYMPHOID THYMOSIN Beta 4
US8383576B2 (en) * 2005-06-17 2013-02-26 Regenerx Biopharmaceuticals, Inc. LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized
WO2008108927A2 (en) * 2007-03-06 2008-09-12 Regenerx Biopharmaceuticals, Inc. Methods and compositions for stabilizing polypeptides
CA2691914C (en) * 2007-07-11 2012-06-26 Pfizer Inc. Pharmaceutical compositions and methods of treating dry eye disorders
US20120264681A1 (en) * 2010-11-08 2012-10-18 Healor Ltd. Buffered ophthalmic compositions and methods of use thereof
WO2016064078A1 (ko) * 2014-10-22 2016-04-28 주식회사 지트리비앤티 티모신 베타 4를 함유하는 조성물 및 이를 포함하는 약학적 제형

Similar Documents

Publication Publication Date Title
ES2587869T3 (es) Composición oftálmica de olopatadina de concentración alta
JP2016539921A5 (enExample)
RU2016119746A (ru) Стабильный состав инсулина глулизин
JP2015526467A5 (enExample)
JP2017214429A5 (enExample)
TWI629057B (zh) 眼科用組成物
JP5873573B2 (ja) 水性眼科組成物
JP2021107464A (ja) 眼科組成物
JPH1160505A (ja) 防腐組成物
JP2022008964A (ja) カラーコンタクトレンズ用眼科組成物
JP2013535472A5 (enExample)
HRP20201696T1 (hr) Farmaceutska parenteralna formulacija koja sadrži kargluminsku kiselinu
JP2013518051A5 (enExample)
RU2012134065A (ru) Альфа-2 адренергический агонист, обладающий эффектом длительного снижения внутриглазного давления
JP2023093761A (ja) 異物感改善用眼科組成物
JP6921757B2 (ja) 眼科組成物
PH12022551295A1 (en) Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunction in fontan-palliated patients
JP5922505B2 (ja) グリチルリチン酸含有水性眼科組成物
ES2974884T3 (es) Composición de colirio para reducir la presión intraocular
CN104000809B (zh) 一种防治冠心病心绞痛的药物组合物及其应用
TW201622700A (zh) 水性醫藥組成物
EP3369422A1 (en) External preparation
JP6313598B2 (ja) 眼科用水性組成物
EP2905025B1 (en) Use of 1-adamantylethyloxy-3-morpholino-2-propanol or pharmaceutically acceptable salts thereof in pharmaceutical compositions as a neuroretinal protector
CN103405438B (zh) 曲匹地尔或其药学上可接受的盐在制备防治肺动脉高压药物中的应用